Characterization of a new CCCTC-binding factor binding site as a dual regulator of Epstein-Barr virus latent infection
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011078 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Sun Hee Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Vessel-Organ Interaction Research Center, Research Institute of Pharmaceutical Science, Kyungpook National University, Daegu, Ko…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, MicroRNAs, Latent Infection. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Foundation of Korea, the Priority Research Centers Program through the National Research Foundation funded by the Korean Ministry of Education, Science, and Technology, the National Research Foundation of Korea grant funded by the Korean Government.
Abstract (Originalsprache)
Distinct viral gene expression characterizes Epstein-Barr virus (EBV) infection in EBV-producing marmoset B-cell (B95-8) and EBV-associated gastric carcinoma (SNU719) cell lines. CCCTC-binding factor (CTCF) is a structural chromatin factor that coordinates chromatin interactions in the EBV genome. Chromatin immunoprecipitation followed by sequencing against CTCF revealed 16 CTCF binding sites in the B95-8 and SNU719 EBV genomes. The biological function of one CTCF binding site (S13 locus) located on the Bam HI A right transcript (BART) miRNA promoter was elucidated experimentally. Microscale thermophoresis assay showed that CTCF binds more readily to the stable form than the mutant form of the S13 locus. EBV BART miRNA clusters encode 22 miRNAs, whose roles are implicated in EBV-related cancer pathogenesis. The B95-8 EBV genome lacks a 11.8-kb EcoR I C fragment, whereas the SNU719 EBV genome is full-length. ChIP-PCR assay revealed that CTCF, RNA polymerase II, H3K4me3 histone, and H3K9me3 histone were more enriched at S13 and S16 (167-kb) loci in B95-8 than in the SNU719 EBV genome. 4C-Seq and 3C-PCR assays using B95-8 and SNU719 cells showed that the S13 locus was associated with overall EBV genomic loci including 3-kb and 167-kb region in both EBV genomes. We generated mutations in the S13 locus in bacmids with or without the 11.8-kb BART transcript unit (BART(+/-)). The S13 mutation upregulated BART miRNA expression, weakened EBV latency, and reduced EBV infectivity in the presence of Eco RI C fragment. Another 3C-PCR assay using four types of BART(+/-)·S13(wild-type(Wt)/mutant(Mt)) HEK293-EBV cells revealed that the S13 mutation decreased DNA associations between the 167-kb region and 3-kb in the EBV genome. Based on these results, CTCF bound to the S13 locus along with the 11.8-kb Eco RI C fragment is suggested to form an EBV 3-dimensional DNA loop for coordinated EBV BART miRNA expression and infectivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Vessel-Organ Interaction Research Center, Research Institute of Pharmaceutical Science, Kyungpook National University, Daegu, Korea.
- Department of Systems Biotechnology, Chung-Ang University, Anseong, Korea.
- Institute of Molecular Biology, University of Oregon, Eugene, Oregon, United States of America.
- Department of Computer Science and Engineering, Kyungpook National University, Daegu, Korea.
- Duksung Innovative Drug Center, College of Pharmacy, Duksung Women's University, Seoul, Korea.
ORCID-Profile: Hyosun Cho, Hyojeung Kang
Förderung
- the National Research Foundation of Korea
- the Priority Research Centers Program through the National Research Foundation funded by the Korean Ministry of Education, Science, and Technology
- the National Research Foundation of Korea grant funded by the Korean Government
- the 4TH BK21 project (Educational Research Group for Platform development of management of emerging infectious disease) funded by the Korean ministry of educat…
Zitieren
APA
Lee, S. H., Kim, K. D., Cho, M., Huh, S., An, S. H., Seo, D., Kang, K., Lee, M., Tanizawa, H., Jung, I., Cho, H., & Kang, H. (2023). Characterization of a new CCCTC-binding factor binding site as a dual regulator of Epstein-Barr virus latent infection. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011078
Vancouver
Lee SH, Kim KD, Cho M, Huh S, An SH, Seo D, et al. Characterization of a new CCCTC-binding factor binding site as a dual regulator of Epstein-Barr virus latent infection. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011078
BibTeX
@article{Lee2023,
author = {Lee, Sun Hee and Kim, Kyoung-Dong and Cho, Miyeon and Huh, Sora and An, Seong Ho and Seo, Donghyun and Kang, Kyuhyun and Lee, Minhee and Tanizawa, Hideki and Jung, Inuk and Cho, Hyosun and Kang, Hyojeung},
title = {Characterization of a new CCCTC-binding factor binding site as a dual regulator of Epstein-Barr virus latent infection},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011078}
}
EUVIMED